ALPHAEON Corporation announces the introduction of the skIN3 line of products, featuring DermaTriPlex technology to address the visual signs of aging.
The line, which includes day, night, eye, and lip care treatments, contains Novasome, RHA Resilient Hyaluronic Acid, and TruCollagen. This combination of ingredients is designed to help reduce the appearance of fine lines and wrinkles with the use of concentrated plant extracts that provide enhanced moisturizing and smoothing benefits, according to a media release from the company.
DermaTriPlex technology, formulated by equity holder in ALPHAEON and Strathspey Crown Holdings Dr Mark Pinsky, helps fight the appearance of fine lines and wrinkles by invigorating the skin with intensive moisture for plump-looking, smooth skin, the release continues.
“I believe that regardless of the planned procedure, surgical or nonsurgical, the foundation to looking pretty is beautiful skin,” Pinsky says in the release. “With that in mind, I worked with ALPHAEON to commercialize the DermaTriPlex technology and the full skIN3 line for patients who see wrinkles and fine lines as a concern, but are seeking an alternative and don’t have time for a complex daily regimen.”
“With this new line, ALPHAEON is making available the next generation of products designed to address the needs of patients everywhere who are seeking the best options in facial skincare,” states September Riharb, vice president of marketing at ALPHAEON.
“This underscores our commitment to delivering the best beauty solutions and is a true example of the intersection of technology innovation and beauty that we are striving to achieve,” she adds.
For more information, visit ALPHAEON.
[Source(s): ALPHAEON, PR Newswire]